SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001048477-23-000066
Filing Date
2023-12-28
Accepted
2023-12-28 13:00:12
Documents
3
Period of Report
2023-12-27

Document Format Files

Seq Description Document Type Size
1 FORM 3 wk-form3_1703786402.html 3  
1 FORM 3 wk-form3_1703786402.xml 3 1609
2 EX-24 section16filingspowerofa.htm EX-24 4082
3 section16filingspowerofa001.jpg GRAPHIC 239523
  Complete submission text file 0001048477-23-000066.txt   337124
Mailing Address 105 DIGITAL DRIVE NOVATO CA 94949
Business Address 105 DIGITAL DRIVE NOVATO CA 94949 4155066700
BIOMARIN PHARMACEUTICAL INC (Issuer) CIK: 0001048477 (see all company filings)

IRS No.: 680397820 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O AMBIT BIOSCIENCES CORPORATION 11080 ROSELLE STREET SAN DIEGO CA 92121
Business Address
Countouriotis Athena (Reporting) CIK: 0001571469 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-26727 | Film No.: 231521339